Large Cap Healthcare
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Abbott
ABT
$189B
| $189B | $109.29 | 1.06% |
|
| 2 |
2
Novo Nordisk
NVO
$181B
| $181B | $41.09 | 0.96% |
|
| 3 |
3
Pfizer
PFE
$168B
| $168B | $29.45 | 0.31% |
|
| 4 |
4
Danaher
DHR
$166B
| $166B | $235.31 | 0.34% |
|
| 5 |
5
Intuitive Surgical
ISRG
$156B
| $156B | $449.53 | 0.11% |
|
| 6 |
6
Vertex Pharmaceuticals
VRTX
$139B
| $139B | $547.03 | 0.16% |
|
| 7 |
7
Medtronic
MDT
$130B
| $130B | $101.61 | 0.02% |
|
| 8 |
8
Bristol-Myers Squibb
BMY
$129B
| $129B | $62.91 | 0.18% |
|
| 9 |
9
McKesson
MCK
$125B
| $125B | $1,079.79 | 0.26% |
|
| 10 |
10
Stryker
SYK
$121B
| $121B | $318.79 | 1.7% |
|
| 11 |
11
Sanofi
SNY
$116B
| $116B | $48.43 | 0.41% |
|
| 12 |
12
CVS Health
CVS
$115B
| $115B | $89.52 | 0.57% |
|
| 13 |
13
HCA Healthcare
HCA
$106B
| $106B | $506.04 | 0.32% |
|
| 14 |
14
GSK
GSK
$101B
| $101B | $50.60 | 1.23% |
|
| 15 |
15
Moderna
MRNA
$101B
| $101B | $248.69 | 0.85% |
|
| 16 |
16
Regeneron Pharmaceuticals
REGN
$99.2B
| $99.2B | $959.41 | 4.73% |
|
| 17 |
17
Elevance Health
ELV
$92.8B
| $92.8B | $429.48 | 0.04% |
|
| 18 |
18
Cigna
CI
$79.4B
| $79.4B | $301.45 | 0.55% |
|
| 19 |
19
Cencora
COR
$66.8B
| $66.8B | $349.88 | 0.34% |
|
| 20 |
20
Takeda Pharmaceutical
TAK
$66.6B
| $66.6B | $20.84 | 0.43% |
|
| 21 |
21
Boston Scientific
BSX
$65.4B
| $65.4B | $45.13 | 0.96% |
|
| 22 |
22
Cardinal Health
CAH
$64.1B
| $64.1B | $277.45 | 0.24% |
|
| 23 |
23
argenx
ARGX
$61.5B
| $61.5B | $977.58 | 0.62% |
|
| 24 |
24
Edwards Lifesciences
EW
$60.8B
| $60.8B | $105.81 | 1.73% |
|
| 25 |
25
Becton Dickinson
BDX
$58.4B
| $58.4B | $214.52 | 0.9% |
|
Large Cap Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 108 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.7T.
The largest by market cap are Abbott (ABT) at $189B, Novo Nordisk (NVO) at $181B and Pfizer (PFE) at $168B.
Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 326 funds opened new positions, taking total fund holders up 198 (10%) quarter-over-quarter.
- Combined market cap: $4.7T across 108 stocks.
- Large Cap: market cap between $10B and $200B.
- Largest constituent: Abbott (ABT), $189B market cap.
- Most net new fund positions in Q2 2026: CVS Health (CVS), +198 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.